VaxGen to Present Progress Update in Seattle on April 6

Apr 02, 2001, 01:00 ET from VaxGen, Inc.

    BRISBANE, Calif., April 2 /PRNewswire/ -- Donald P. Francis, M.D., D.Sc.,
 president of VaxGen, Inc. (Nasdaq: VXGN), will present an update to investors
 in Seattle this Friday.  Dr. Francis will discuss some of VaxGen's recent
 milestones and respond to questions about the company's progress in developing
 HIV/AIDS vaccines.  VaxGen is the only company with preventive HIV/AIDS
 vaccines in Phase III clinical trials, the final stage before regulatory
 approval.
    (Photo:  http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO )
     Investors from the Seattle area are encouraged to attend one of two
 presentations, at 12:00 noon or at 4:30 p.m., Friday, April 6.  The
 presentations will take place at the Washington Athletic Club,
 1325 Sixth Avenue, Seattle, Washington 98101.  Those interested in attending
 must call 206-344-6631 to RSVP.
      VaxGen is located in Brisbane, Calif.  For more information, please visit
 the company's web site at www.vaxgen.com.
 
 

SOURCE VaxGen, Inc.
    BRISBANE, Calif., April 2 /PRNewswire/ -- Donald P. Francis, M.D., D.Sc.,
 president of VaxGen, Inc. (Nasdaq: VXGN), will present an update to investors
 in Seattle this Friday.  Dr. Francis will discuss some of VaxGen's recent
 milestones and respond to questions about the company's progress in developing
 HIV/AIDS vaccines.  VaxGen is the only company with preventive HIV/AIDS
 vaccines in Phase III clinical trials, the final stage before regulatory
 approval.
    (Photo:  http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO )
     Investors from the Seattle area are encouraged to attend one of two
 presentations, at 12:00 noon or at 4:30 p.m., Friday, April 6.  The
 presentations will take place at the Washington Athletic Club,
 1325 Sixth Avenue, Seattle, Washington 98101.  Those interested in attending
 must call 206-344-6631 to RSVP.
      VaxGen is located in Brisbane, Calif.  For more information, please visit
 the company's web site at www.vaxgen.com.
 
 SOURCE  VaxGen, Inc.